Intravenous BCG-mediated protection against tuberculosis requires CD4+ T cells and CD8α+ lymphocytes
The Journal of Experimental Medicine,
Год журнала:
2025,
Номер
222(4)
Опубликована: Янв. 17, 2025
Tuberculosis
(TB)
is
a
major
health
burden
worldwide
despite
widespread
intradermal
(ID)
BCG
vaccination
in
newborns.
We
previously
demonstrated
that
changing
the
route
and
dose
from
5
×
105
CFUs
ID
to
107
i.v.
resulted
prevention
of
Mycobacterium
tuberculosis
(Mtb)
infection
TB
disease
highly
susceptible
nonhuman
primates.
Identifying
immune
mechanisms
protection
following
will
facilitate
development
more
effective
vaccines
against
TB.
Here,
we
depleted
lymphocyte
subsets
prior
during
Mtb
challenge
BCG-vaccinated
macaques
identify
those
necessary
for
protection.
Depletion
adaptive
CD4
T
cells,
but
not
CD8αβ
loss
with
increased
burdens
dissemination,
indicating
cells
are
critical
BCG-mediated
unconventional
CD8α-expressing
lymphocytes
(NK
innate
CD4+CD8α+
double-positive
cells)
abrogated
most
BCG-immunized
macaques,
supporting
further
investigation
into
which
these
cell
contribute
after
vaccination.
Язык: Английский
Deconvoluting the interplay of innate and adaptive immunity in BCG-induced nonspecific and TB-specific host resistance
The Journal of Experimental Medicine,
Год журнала:
2025,
Номер
222(4)
Опубликована: Фев. 28, 2025
BCG
is
the
oldest
vaccine
in
continuous
use.
While
current
intradermal
vaccination
regimens
confer
limited
protection
outside
context
of
pediatric
extrapulmonary
tuberculosis
(TB),
promising
new
data
indicate
that
when
administered
mucosally
or
intravenously
at
a
higher
dose,
can
induce
sterilizing
immunity
against
pulmonary
TB
nonhuman
primates.
also
known
to
promote
nonspecific
host
resistance
variety
unrelated
infections
and
standard
immunotherapy
for
bladder
cancer,
suggesting
this
innate
immune
function
may
contribute
its
protective
role
TB.
Here,
we
propose
both
mycobacterial-specific
off-target
effects
depend
on
interplay
adaptive
cells
cytokines
they
produce,
elucidation
interaction
should
be
major
strategy
development
more
effective
BCG-based
vaccines
immunotherapies.
Язык: Английский